loading

The weight loss revolution is now

IT IS NOW RECOGNIZED THAT BIOLOGY-BASED APPROACHES ARE THE KEY TO WEIGHT LOSS.
The appetite control and satiety hormones include GLP-1, GIP, PYY, amylin and glucagon. These hormones are being targeted by the new synthetic weight loss injectable compounds. In today’s busy world, many people are rapid eaters who consume more food than is needed BEFORE their own natural gut hormones can signal fullness.
By slowing food intake with Scientific Intake’s SmartByte® device, these naturally occurring endogenous hormones are secreted by the gut and pancreas, signaling satiety and controlling appetite without the use of systemic drugs.

Peer reviewed research conducted at the Pennington Biomedical Research Center and published in OBESITY validated that SmartByte® users are satisfied on 23% less food than non-users. These results align with the new injected pharmaceutical compounds.

Weight loss is the fastest growing category in healthcare
More than 200,000,000 US adults are overweight or obese

The two pharma companies that own metabolic hormone based weight loss have a combined value of $1.3 Trillion

Company

Novo Nordisk

Eli Lilly

MARKET CAP MAY 2022

$232B

$270B

MARKET CAP MAY 2023

$374B

$415B

SHARE PRICE MAY 2022

$103

$295

SHARE PRICE MAY 2023

$168

$436

60%+
Growth

COMPANY

Novo Nordisk

-

Eli Lilly

-

-

Share Price

Market Cap

Share Price

Market Cap

jan 1, 2021

$35

$151B

$166

$158B

Sept 25, 2024

$127

$561B

$928

$835B

Now there is a safer, more affordable way to use GLP-1 and GIP to get a share of the largest healthcare market in history.

Scientific Intake’s proven, FDA cleared solution fills

“The Treatment Gap” for millions of consumers

Because…
  • Many don’t want to inject synthetic appetite hormones when their natural ones can be activated
  • Many can’t tolerate the side effects of the pharmaceutical compounds
  • Many can’t afford the exorbitant cost
  • Many will eventually abandon the drugs and seek ways to maintain the weight lost

The introduction of our natural solution will generate patient interest and major media attention to build awareness quickly.

Controlling Hunger, Appetite and Satiety Is the Key to Successful Weight Management

Our Solution

Placed only when eating, Scientific Intake’s SmartByte® decreases the capacity of the oral cavity, causing three important things to happen:
Smaller bites and thorough chewing
Increased oral processing, taste and savoring of food
Time for the stomach to signal the brain and register satiety before overeating

SmartByte® was invented by a woman with Torus Palatinus, a benign lobulation in the palate, who credited her life-long healthy BMI to her slower eating and feeling satisfied on less food. She hypothesized that a removable space occupying device would mimic her results in others. Multiple published clinical studies have validated the safety and efficacy of her simple, safe solution.

Research conducted over the past 30 years has produced a large body of science linking rapid eating to obesity.

SmartByte® is the only FDA designated non-significant risk weight management device that works at the gateway to the body. It is non-systemic and there are no side effects.  

Scientific Intake’s intraoral device slows eating, which allows time for nature’s defense system against overeating to function as intended.

For additional support, every SmartByte has an embedded, proprietary microsensor that monitors compliance. This data can be uploaded to an App that monitors usage and calculates progress to goal weight as well as communicating reminders and encouragement. The app can be enhanced with robust personalized content to generate incremental and ongoing revenue. 

Scientific Intake’s peer reviewed, published clinical research studies and FDA clearance assure SmartByte® is safe and effective.

GLOBAL REGULATORY CLEARANCES ACHIEVED
FDA (US)
CE Mark (EU)
TGA (Australia)
Health Canada (CA)
Anvisa (Brazil)

SMARTBYTE® WILL SERVE A GREATER SOCIETAL GOOD WHILE DRIVING SIGNIFICANT PROFITABILITY

Selling just 1MM SmartByte® devices can deliver $1.8BN in gross revenue.